# A Study of Participants With Advanced Prostate Cancer in Canada

> **NCT03501173** · — · COMPLETED · sponsor: **Janssen Inc.** · enrollment: 374 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03501173
- **Lead sponsor:** Janssen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-12
- **Primary completion:** 2023-07-14
- **Final completion:** 2023-07-14
- **Target enrollment:** 374 (ACTUAL)
- **Last updated:** 2023-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03501173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03501173, "A Study of Participants With Advanced Prostate Cancer in Canada". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03501173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*